BioCentury
ARTICLE | Financial News

Oncologie raises $16.5M for dual U.S.-China strategy

June 8, 2018 4:46 PM UTC

Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal bioVenture Partners China. Nan Fung Life Sciences, China Merchant Bank Investments and Volcanics Ventures also joined the round.

Oncologie plans to develop in-licensed cancer assets in China and the U.S. simultaneously. Oncologie founder, President and CEO Laura Benjamin told BioCentury the company is focusing on cancers prevalent in Asia -- including gastric, liver and lung cancers...